Eric Benevich

Insider Reports History

Entity
Individual
Location
C/O Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, CA
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Benevich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Common Stock 40.8K $5.44M $133.36 Apr 15, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Restricted Stock Unit 7.85K $1.04M $132.85 Feb 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Non-Qualified Stock Option 0 $0 $81.05 Apr 15, 2024 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 100K Dec 10, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Commercial Officer Stock Option 39.4K Feb 13, 2024 Direct

Insider Reports Filed by Eric Benevich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATYR aTYR PHARMA INC Dec 10, 2024 1 $0 4 Dec 12, 2024 Director
ATYR aTYR PHARMA INC Dec 10, 2024 0 $0 3 Dec 12, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC Apr 15, 2024 6 -$2.64M 4 Apr 17, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Mar 14, 2024 6 -$10.5M 4 Mar 15, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 28, 2024 6 -$10.1M 4 Feb 29, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2024 3 -$146K 4 Feb 15, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2024 2 -$313K 4 Feb 8, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2024 1 -$170K 4 Feb 2, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Aug 21, 2023 1 -$172K 4 Aug 23, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2023 4 -$2.02M 4 Feb 8, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2023 1 -$133K 4 Feb 2, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 6, 2023 3 -$50K 4 Jan 10, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Nov 30, 2022 9 -$6.3M 4 Dec 1, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Nov 8, 2022 6 -$3.09M 4 Nov 10, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Nov 2, 2022 6 -$1.17M 4 Nov 4, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Oct 17, 2022 1 -$550K 4 Oct 19, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Feb 7, 2022 4 -$411K 4 Feb 9, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2022 2 $0 4 Feb 2, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Aug 16, 2021 1 -$504K 4 Aug 18, 2021 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Nov 2, 2020 0 $0 4/A May 11, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC Jun 1, 2018 0 $0 4/A May 11, 2023 Chief Commercial Officer